Rachel Braun Scherl interview (SoundCloud link)

Rachel Braun Scherl is a proven expert in business-building for female health companies. Through SPARK Solutions for Growth, Rachel has driven innovation and created revenue growth for leading pharma, beauty and consumer health companies, including Allergan, Johnson & Johnson, Pfizer, Bayer, Merck, and Church & Dwight. Her brand experience includes Advil, Aveeno, Botox, Carefree, Centrum, Chapstick, Coppertone, Johnson’s Baby, Listerine, Neutrogena, ob, Splenda, Stayfree, Trojan, Tylenol and Zestra.

As part of "Rachel Talks" keynote speaker series, Rachel has presented to global audiences on Business-Building, Entrepreneurship, Leadership and Women in Business. Rachel has spoken at prestigious venues, including Johnson & Johnson, Healthcare Businesswomen’s Association, Pennsylvania Conference for Women, The Fuqua School at Duke University, Barnard College Athena Center for Leadership Studies, Stanford University Graduate School of Business, Yale School of Management, Fairleigh Dickinson Silberman College of Business and Montclair State University Feliciano Center for Entrepreneurship. 

Career Highlights:

  • Rachel has built a client base including some of the world’s leading organizations as Principal at SPARK;
  • As Co-Founder of Semprae Laboratories, Rachel led the growth of the company leading to its sale to Innovus Pharmaceuticals Inc.
  • Recipient of Best 50 Women in Business by NJBiz , SmartCEO’s BRAVA Award and JWI’s 10 Women to Watch.


Rachel has been featured for her work in Women’s Health and Leadership on ABC News, CBS, msnbc, AdAge, The New York Times, The Philadelphia Inquirer, Lifetime, Oprah Radio, FOX News, WPIX, Inc., & Forbes. She has a regular column at Huffington Post and writes for Inc. Rachel is a Board member of illumai & Advisory Board Member at Center for Entrepreneurship & Innovation, The Fuqua School of Business. 

Rachel is open to LinkedIn requests from Marketing Directors & Meeting Planners of Women in Business & Healthcare Conferences.